Sentinel Heartworm Drugs Moving to Virbac
October 31, 2014
Eli Lilly and Co. has found a buyer for the U.S. rights to Sentinel Flavor Tabs and Sentinel Spectrum as part of its acquisition of Novartis Animal Health. The Novartis trademarks, patents and customer lists for the two canine antiparasitics will be transferred to Virbac Animal Health of Fort Worth, Texas, upon Federal Trade Commission… Continue reading...